{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:29:50Z","timestamp":1775561390254,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T00:00:00Z","timestamp":1131580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00296-005-0073-4","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T09:45:39Z","timestamp":1131615939000},"page":"445-453","source":"Crossref","is-referenced-by-count":25,"title":["Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis"],"prefix":"10.1007","volume":"26","author":[{"given":"R.","family":"Nuti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Caudarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"D\u2019Erasmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Isaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Luisetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Oriente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ortolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,10]]},"reference":[{"issue":"Suppl 3","key":"73_CR1","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF03194338","volume":"7","author":"HF DeLuca","year":"1997","unstructured":"DeLuca HF (1997) 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis. Osteoporos Int 7(Suppl 3):S24\u2013S29","journal-title":"Osteoporos Int"},{"issue":"2","key":"73_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF02378983","volume":"10","author":"Y Hayashi","year":"1992","unstructured":"Hayashi Y, Fujita T, Inoue T (1992) Decrease of vertebral fracture in osteoporotics by administration of 1\u03b1-hydroxyvitamin D3. J Bone Miner Metabol 10(2):184\u2013188","journal-title":"J Bone Miner Metabol"},{"issue":"6","key":"73_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","volume":"326","author":"MW Tilyard","year":"1992","unstructured":"Tilyard MW, Spears GF, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. New Engl J Med 326(6):357\u2013362","journal-title":"New Engl J Med"},{"key":"73_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003086-199403000-00033","volume":"300","author":"J Menczel","year":"1994","unstructured":"Menczel J, Foldes J, Steinberg R, Leichter I, Shalita B, Bdolah-Abram T, Kadosh S, Mazor Z, Ladkani D (1994) Alfacalcidol (Alpha D3) and calcium in osteoporosis. Clin Orthop 300:241\u2013247","journal-title":"Clin Orthop"},{"key":"73_CR5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","volume":"54","author":"H Orimo","year":"1994","unstructured":"Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N (1994) Effects of 1\u03b1-hydroxyvitamin D3 on lumbar bone mineral density, vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370\u2013376","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"73_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.43.211","volume":"43","author":"M Shiraki","year":"1996","unstructured":"Shiraki M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2\u00a0years treatment of osteoporosis with 1\u03b1-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43(2):211\u2013220","journal-title":"Endocr J"},{"issue":"5","key":"73_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2165\/00044011-199611050-00003","volume":"11","author":"R Nuti","year":"1996","unstructured":"Nuti R, Martini G, Valenti R, Giovanni S (1996) Controlled study on the metabolic and absorptiometric effects of calcitriol in involutional osteoporosis. Clin Drug Invest 11(5):270\u2013277","journal-title":"Clin Drug Invest"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1210\/jcem.86.8.7703","volume":"86","author":"JC Gallagher","year":"2001","unstructured":"Gallagher JC, Fowler SE, Detter JR, Sherman SS (2001) Combination treatment with estrogen and calcitriol in prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618\u20133628","journal-title":"J Clin Endocrinol Metab"},{"key":"73_CR9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/er.2001-8002","volume":"23","author":"E Papadimitropoulos","year":"2002","unstructured":"Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, Cranney A, Adachi J, Tugwell P, Josse R, Greenwood C, Guyatt G (2002) The osteoporosis methodology group, and the osteoporosis research advisory group. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560\u2013569","journal-title":"Endocr Rev"},{"issue":"3","key":"73_CR10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"R Lindsay","year":"2001","unstructured":"Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320\u2013323","journal-title":"JAMA"},{"issue":"9","key":"73_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-113-9-649","volume":"113","author":"JC Gallagher","year":"1990","unstructured":"Gallagher JC, Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med 113(9):649\u2013655","journal-title":"Ann Intern Med"},{"key":"73_CR12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01623386","volume":"6","author":"RM Francis","year":"1996","unstructured":"Francis RM, Boyle IT, Moniz C, Sutcliffe AM, Davis BS, Beastall GH, Cowan RA, Downes N (1996) A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures. Osteoporos Int 6:284\u2013290","journal-title":"Osteoporos Int"},{"key":"73_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00296-003-0361-9","volume":"24","author":"JD Ringe","year":"2004","unstructured":"Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW (2004) Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int 24:63\u201370","journal-title":"Rheumatol Int"},{"issue":"5","key":"73_CR14","first-page":"268","volume":"23","author":"SH Scharla","year":"2003","unstructured":"Scharla SH, Schacht E, Bawey S, Kamilli I, Holle D, Lempert UG (2003) Pleiotropic effects of alfacalcidol in elderly patients with rheumatoid arthritis. Arthritis Rheuma 23(5):268\u2013274","journal-title":"Arthritis Rheuma"},{"key":"73_CR15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy MC, Arlot ME, Duboeuf F et al. (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637\u20131642","journal-title":"N Engl J Med"},{"key":"73_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s001980200023","volume":"13","author":"MC Chapuy","year":"2002","unstructured":"Chapuy MC, Pamphile R, Paris E et al. (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13:257\u2013264","journal-title":"Osteoporos Int"},{"key":"73_CR17","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/ajcn\/77.5.1324","volume":"77","author":"L Cooper","year":"2003","unstructured":"Cooper L, Clifton-Bligh PB, Nery ML et al. (2003) Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 77:1324\u20131329","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"73_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2008-1046694","volume":"19","author":"H Orimo","year":"1994","unstructured":"Orimo H (1994) Clinical application of 1\u03b1(OH)D3 in Japan. Akt Rheumatol 19(Suppl 1):27\u201330","journal-title":"Akt Rheumatol"},{"issue":"Suppl 1","key":"73_CR19","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1007\/BF01621903","volume":"3","author":"Y Nishii","year":"1993","unstructured":"Nishii Y, Sato K, Kobayashi (1993) The development of vitamin D3 analogues for the treatment of Osteoporosis. Osteoporosis Int 3(Suppl 1):S190\u2013S193","journal-title":"Osteoporosis Int"},{"key":"73_CR20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s002239900705","volume":"65","author":"E Schacht","year":"1999","unstructured":"Schacht E (1999) Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 65:317\u2013327","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 1","key":"73_CR21","first-page":"S16","volume":"19","author":"F Grassi","year":"2004","unstructured":"Grassi F, Leavey JK, Dark K, Qian W, Weitzmann MN, Pacifici R (2004) Bone marrow restricted antigen presentation by dendritic cells induces T cell activation and T CELL TNF production in ovariectomized mice. J Bone Miner Res 19(Suppl 1):S16","journal-title":"J Bone Miner Res"},{"issue":"2","key":"73_CR22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/endo-126-2-1053","volume":"126","author":"RL Horst","year":"1990","unstructured":"Horst RL, Goff JP, Reinhardt TA (1990) Advancing age results in reduction of intestinal and bone 1,25-dihydroxy-vitamin D receptors. Endocrinology 126(2):1053\u20131057","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"73_CR23","first-page":"S246","volume":"19","author":"PB Rapuri","year":"2004","unstructured":"Rapuri PB, Gallagher JC, Haynatzka V (2004) Interaction between vitamin D receptor and estrogen receptor genotypes does not influence BMD, rate of bone loss and the response to treatment with calcitriol or estrogen in elderly women. J Bone Miner Res 19(Suppl 1):S246","journal-title":"J Bone Miner Res"},{"key":"73_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s002239900703","volume":"65","author":"BEC Nordin","year":"1999","unstructured":"Nordin BEC, Need AG, Morris HA, Horowitz M (1999) The special role of \u201cHormonal\u201d forms of Vitamin D in the treatment of osteoporosis. Calcif Tissue Int 65:307\u2013310","journal-title":"Calcif Tissue Int"},{"key":"73_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002239900702","volume":"65","author":"KHW Lau","year":"1999","unstructured":"Lau KHW, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 65:295\u2013306","journal-title":"Calcif Tissue Int"},{"key":"73_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00296-004-0454-0","volume":"24","author":"JD Ringe","year":"2004","unstructured":"Ringe JD, Schacht E (2004) Prevention and therapy of osteoporosis: the respective roles of plain vitamin D and alfacalcidol. Rheumatol Int 24:189\u2013197","journal-title":"Rheumatol Int"},{"issue":"10","key":"73_CR27","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/mend.13.10.0362","volume":"13","author":"XY Li","year":"1999","unstructured":"Li XY, Boudjelal M, Xiao JH, Peng ZH, Asuru A, Kang S, Fisher GJ, Voorhees JJ (1999) 1,25-dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking Ubiquitin\/Proteasome-mediated degradation in human skin. Mol Endocrinol 13(10):1686\u20131694","journal-title":"Mol Endocrinol"},{"key":"73_CR28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1359\/jbmr.2002.17.4.622","volume":"17","author":"T Shibata","year":"2002","unstructured":"Shibata T, Shira-Ishi A, Sato T, Masaki T, Sasaki A, Masuda Y, Hishiya A, Ishikura N, Higashi S, Uchida Y, Saito M, Ito M, Ogata E, Watanabe K, Ikeda K (2002) Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow. J Bone Miner Res 17:622\u2013629","journal-title":"J Bone Miner Res"},{"key":"73_CR29","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/1381612043383818","volume":"10","author":"M Driel van","year":"2004","unstructured":"van Driel M, Pols HAP, van Leeuwen JPTM (2004) Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des 10:2535\u20132555","journal-title":"Curr Pharm Des"},{"key":"73_CR30","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","volume":"15","author":"HF DeLuca","year":"2001","unstructured":"DeLuca HF, Cantorna MT (2001) Vitamin D. Its role and uses in immunology. FASEB J 15:2579\u20132585","journal-title":"FASEB J"},{"key":"73_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","volume":"8","author":"C Mathieu","year":"2002","unstructured":"Mathieu C, Adorini L (2002) The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 8:174\u2013179","journal-title":"Trends Mol Med"},{"key":"73_CR32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1359\/jbmr.2000.15.4.770","volume":"15","author":"A Shiraishi","year":"2000","unstructured":"Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, Ogata E (2000) Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct action from estrogen. J Bone Mineral Res 15:770\u2013779","journal-title":"J Bone Mineral Res"},{"key":"73_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002239900704","volume":"65","author":"A Shiraishi","year":"1999","unstructured":"Shiraishi A, Higashi S, Ohkawa H, Kubodera N, Hirasawa T, Ezawa I, Ikeda K, Ogata E (1999) The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif Tissue Int 65:311\u2013316","journal-title":"Calcif Tissue Int"},{"key":"73_CR34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1254\/jjp.89.255","volume":"89","author":"M Ito","year":"2002","unstructured":"Ito M, Azuma Y, Takagi H, Komoriya K, Ohta T, Kawaguchi H (2002) Curative effect of combined treatment with alendronate and 1\u03b1-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats. Jpn. J. Pharmacol 89:255\u2013266","journal-title":"Jpn. J. Pharmacol"},{"key":"73_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2004.03.005","volume":"35","author":"G Duque","year":"2004","unstructured":"Duque G, El Abdaimi K, Henderson JE, Lomri A, Kremer R (2004) Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways. Bone 35:57\u201364","journal-title":"Bone"},{"issue":"Suppl 1","key":"73_CR36","first-page":"S483","volume":"19","author":"AA Reszka","year":"2004","unstructured":"Reszka AA, Pun S, Rodan GA, Freedman LP, Kimmel DB (2004) Bone anabolic effects of 1,25(OH)2 Vitamin D3 are detected only in the presence of a powerful antiresorptive. J Bone Min Res 19(Suppl 1):S483","journal-title":"J Bone Min Res"},{"issue":"12","key":"73_CR37","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","volume":"98","author":"MD Griffin","year":"2001","unstructured":"Griffin MD, Lutz WH, Phan VA, Bachmann LA, McKean DJ, Kumar R (2001) Dendritic cell modulation by 1\u03b1, 25-dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U.S.A. 98(12):6800\u20136805","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"2","key":"73_CR38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj.44.299","volume":"44","author":"T Kato","year":"1997","unstructured":"Kato T, Chen JT, Katase K, Hirai Y, Hasumi K, Ogata E, Shiraki Y, Shiraki M (1997) Effect of 1\u03b1-hydroxyvitamin D3 on loss of bone mineral density immediately after artificial menopause. Endocr J 44(2):299\u2013304","journal-title":"Endocr J"},{"key":"73_CR39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) The osteoporosis methodology group, and the osteoporosis research advisory group. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570\u2013578","journal-title":"Endocr Rev"},{"key":"73_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00198-003-1570-5","volume":"15","author":"F Richy","year":"2004","unstructured":"Richy F, Ethgen O, Bruyere O, Reginster J-Y (2004) Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 15:301\u2013310","journal-title":"Osteoporos Int"},{"issue":"3","key":"73_CR41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00223-004-0005-4","volume":"76","author":"F Richy","year":"2005","unstructured":"Richy F, Schacht E, Bruy\u00e8re O, Ethgen O, Gourlay M, Reginster JY (2005) Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif Tissue Int 76(3):176\u2013186","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 1","key":"73_CR42","first-page":"S106","volume":"15","author":"O Bock","year":"2004","unstructured":"Bock O, Boerst H, Degner C, Stephan-Oelkers M, Felsenberg D (2004) Underestimated musculoskeletal adverse effects of oral treatment with once weekly alendronate 70\u00a0mg and risedronate 35\u00a0mg: including possibilities for their prevention. Osteoporos Int 15(Suppl 1):S106","journal-title":"Osteoporos Int"},{"issue":"2","key":"73_CR43","first-page":"187","volume":"4","author":"JE Compston","year":"2004","unstructured":"Compston JE (2004) The risks and benefits of HRT. J Musculoskel Neuron Interact 4(2):187\u2013190","journal-title":"J Musculoskel Neuron Interact"},{"key":"73_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5122(03)00130-0","volume":"45","author":"T Ushiroyama","year":"2003","unstructured":"Ushiroyama T, Ikeda A, Sakai M, Higashiyama T, Ueki M (2003) Prevention of postmenopausal bone loss with exchange for short-term HRT for 1\u03b1-hydroxycholecalciferol. Maturitas 45:119\u2013127","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"73_CR45","first-page":"S180","volume":"19","author":"A Shiraishi","year":"2004","unstructured":"Shiraishi A, Ito M, Hayakawa N, Kubota N, Imai N (2004) Combination therapy with alfacalcidol and risedronate at their subtherapeutic doses can additively improve bone dynamics in ovariectomized rat model of osteoporosis. J Bone Miner Res 19(Suppl 1):S180","journal-title":"J Bone Miner Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0073-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0073-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:18:57Z","timestamp":1683281937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0073-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0073-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,10]]}}}